Publication Date
In 2024 | 0 |
Since 2023 | 0 |
Since 2020 (last 5 years) | 0 |
Since 2015 (last 10 years) | 1 |
Since 2005 (last 20 years) | 1 |
Descriptor
Autism | 1 |
Children | 1 |
Cognitive Development | 1 |
Diagnostic Tests | 1 |
Foreign Countries | 1 |
Incidence | 1 |
Intelligence Tests | 1 |
Neurological Impairments | 1 |
Observation | 1 |
Pervasive Developmental… | 1 |
Prediction | 1 |
More ▼ |
Source
Journal of Autism and… | 1 |
Author
Catsman-Berrevoets, C. E. | 1 |
Dieleman, G. C. | 1 |
Dierckx, B. | 1 |
Eijk, S. | 1 |
Elgersma, Y. | 1 |
Legerstee, J. S. | 1 |
Mous, S. E. | 1 |
Oostenbrink, R. | 1 |
Rietman, A. B. | 1 |
de Nijs, P. F. A. | 1 |
ten Hoopen, L. W. | 1 |
More ▼ |
Publication Type
Journal Articles | 1 |
Reports - Research | 1 |
Education Level
Audience
Location
Netherlands | 1 |
Laws, Policies, & Programs
Assessments and Surveys
Autism Diagnostic Observation… | 1 |
Wechsler Preschool and… | 1 |
What Works Clearinghouse Rating
Eijk, S.; Mous, S. E.; Dieleman, G. C.; Dierckx, B.; Rietman, A. B.; de Nijs, P. F. A.; ten Hoopen, L. W.; van Minkelen, R.; Elgersma, Y.; Catsman-Berrevoets, C. E.; Oostenbrink, R.; Legerstee, J. S. – Journal of Autism and Developmental Disorders, 2018
In a non-selected sample of children with Neurofibromatosis type 1 (NF1) the prevalence rate of autism spectrum disorder (ASD) and predictive value of an observational (ADOS)--and questionnaire-based screening instrument were assessed. Complete data was available for 128 children. The prevalence rate for clinical ASD was 10.9%, which is clearly…
Descriptors: Autism, Pervasive Developmental Disorders, Children, Neurological Impairments